Baltimore's biotech strategy

Monday, July 09, 2007

Baltimore is re-evaluating its strategy for life sciences. The report criticizes the array of different initiatives at the local and state level. They are often confusing. In addition, the report focuses on the importance of growing biotech companies...a long term and difficult proposition.

Here's a summary of the update. Read more. You should be able to download the report after registering on this page.

posted by Ed Morrison |

Subscribe with Bloglines

Creative Commons License
This work is licensed under a Creative Commons License.
The Web EDPro Weblog